Begemann, Anaïs
Acuña, Mario A.
Zweier, Markus
Vincent, Marie
Steindl, Katharina
Bachmann-Gagescu, Ruxandra
Hackenberg, Annette
Abela, Lucia
Plecko, Barbara
Kroell-Seger, Judith
Baumer, Alessandra
Yamakawa, Kazuhiro
Inoue, Yushi
Asadollahi, Reza
Sticht, Heinrich
Zeilhofer, Hanns Ulrich
Rauch, Anita
Funding for this research was provided by:
radiz—Rare Disease Initiative Zürich, Clinical Research Priority Program for Rare Diseases of the University of Zurich
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (320030_179547)
Forschungskredit UZH
Josef Huwyler Ruth Bernet-Engeli Stiftung
Article History
Received: 29 October 2018
Accepted: 5 February 2019
First Online: 27 February 2019
Ethics approval and consent to participate
: This study was approved by the ethical committee of the Kanton of Zurich (reference StV 11/09) and informed consent was obtained from the patient or their legal guardians.
: Consent for publication of molecular and clinical data has been obtained from all reported patients or their legal guardians.
: BP has received travel reimbursement from Nutricia in 2018 and honorarium for a lecture on vitamin B6 dependent seizures by Alexion in 2017 (Bad Nauheim). The remaining authors have no conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.